Opendata, web and dolomites

FreeATPOC SIGNED

Towards an instrument-free future of molecular diagnostics at the point-of-care

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FreeATPOC project word cloud

Explore the words cloud of the FreeATPOC project. It provides you a very rough idea of what is the project "FreeATPOC" about.

spreading    sensitive    infrastructure    samples    care    blood    modules    limited    tissues    genetic    regulated    amplification    maintenance    clinically    ligases    global    poor    paper    molecular    infectious    benefits    ing    combines    failures    heaters    started    detection    influenza    plant    acids    big    enzymatically    expand    sensitivities    disadvantage    swabs    monitoring    free    revolutionize    applicability    polymerases    immuno    quantitative    colorimetric    adoption    ultra    diagnostics    resource    instrument    generation    enzymes    substantial       kits    uv    primarily    advantages    interestingly    nucleic    smartphone    ambient    takes    amplified    translation    temperature    extremely    instruments    diagnostic    models    human    poc    market    predictive    slow    societal    latter    combined    time    complexity    final    former    min    hiv    vision    point    newly    electricity    assay    economic    sophisticated    gaining    lab    patient    demonstrated    pathogens    utility    accompanied    technologies    groups    enzymatic    combination    restriction    disease    xylella    acid    outbreaks    advantage    divided    tools    fastidiosa    simplicity   

Project "FreeATPOC" data sheet

The following table provides information about the project.

Coordinator
IDRYMA TECHNOLOGIAS KAI EREVNAS 

Organization address
address: N PLASTIRA STR 100
city: IRAKLEIO
postcode: 70013
website: www.forth.gr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Greece [EL]
 Total cost 3˙052˙500 €
 EC max contribution 3˙052˙500 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IDRYMA TECHNOLOGIAS KAI EREVNAS EL (IRAKLEIO) coordinator 1˙146˙250.00
2    INSTITUT PASTEUR FR (PARIS CEDEX 15) participant 640˙000.00
3    GNOSIS DATA ANALYSIS IDIOTIKI KEFALAIOUCHIKI ETAIREIA EL (HERAKLION) participant 515˙000.00
4    UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST UK (LONDON) participant 401˙250.00
5    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) participant 350˙000.00

Map

 Project objective

Molecular diagnostics is still primarily a lab-based method. Emerging technologies for application at the point of care (POC) or need, i.e., where a patient or a sample is, have started gaining a big part of the molecular diagnostics market. Interestingly, available methods are divided in two groups: sophisticated instruments for ultra-sensitive temperature-regulated enzymatic amplification of nucleic acids and extremely simple paper-based immuno-diagnostic kits. Complexity, the main disadvantage of the former, results in their poor translation to several applications at the POC. Simplicity, often accompanied by failures, of the latter is the reason for their slow adoption even in resource limited areas. Our vision is an instrument-free approach that combines the advantages of both groups, i.e., a method that does not use heaters or modules that require electricity, infrastructure and maintenance, but, still, takes advantage of enzymatically-amplified nucleic acids detection. To achieve the above, novel diagnostic tools for genetic amplification based on ligases, polymerases and restriction enzymes operating at ambient temperature will be developed, combined with quantitative smartphone colorimetric/UV detection. The global applicability of the new approach will be demonstrated during infectious disease (Influenza and HIV) testing in human samples (blood and swabs) and plant pathogens (Xylella fastidiosa) in plant-tissues. In all cases, we aim for a time-to-result of less than 60 min, demonstrated sensitivities down to the clinically/field relevant values and a final cost in the order of $1 per assay. Combination of Free@POC concept with newly developed predictive models will expand its utility to monitoring disease outbreaks and their spreading. This new generation of instrument-free molecular diagnostics is expected to revolutionize nucleic acid analysis at the POC but also in applications beyond resulting in substantial societal as well as economic benefits.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FREEATPOC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FREEATPOC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More  

NOVIRUSES2BRAIN (2019)

''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals

Read More  

SHERO (2019)

Self-HEaling soft RObotics

Read More